Dr Jack Tan
Fellow by Special Election
Jack Tan is a Fellow by Special Election
Jack Tan is a Fellow by Special Election at St Edmund Hall.
Prior to his appointment as a Fellow by Special Election, Jack was the EPA Cephalosporin Early Career Teaching and Research Fellow at St Edmund Hall (2019-2022). Currently, he is a Group Leader & Career Development Fellow at the CAMS-Oxford Institute, Nuffield Department of Medicine. His research focuses on developing novel protein nanoparticle-based vaccines and therapeutic monoclonal antibodies for emerging infectious diseases and understanding the immunology against infectious diseases. He is also a Project Manager of the Caltech-Oxford-Ingenza-CPI consortium which is funded by the Coalition of Epidemic Preparedness Innovations (CEPI) to develop a novel pan SARS-like betacoronavirus vaccine that is designed to induce cross-reactive antibodies against all SARS-CoV-2 variants and other animal SARS-like betacoronavirus that have the potential to cause a pandemic in the future. A human trial of the vaccine is expected to start in Q1 2025.
Where next?
